Stage_2019_Basic.Clin.Pharmacol.Toxicol_125_54

Reference

Title : The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid\/methylphenidate ratios - Stage_2019_Basic.Clin.Pharmacol.Toxicol_125_54
Author(s) : Stage C , Dalhoff K , Rasmussen HB , Schow Guski L , Thomsen R , Bjerre D , Ferrero-Miliani L , Busk Madsen M , Jurgens G
Ref : Basic Clin Pharmacol Toxicol , 125 :54 , 2019
Abstract : Stage_2019_Basic.Clin.Pharmacol.Toxicol_125_54
ESTHER : Stage_2019_Basic.Clin.Pharmacol.Toxicol_125_54
PubMedSearch : Stage_2019_Basic.Clin.Pharmacol.Toxicol_125_54
PubMedID: 30801959
Gene_locus related to this paper: human-CES1

Related information

Gene_locus related to this paper: human-CES1

Citations formats

Stage C, Dalhoff K, Rasmussen HB, Schow Guski L, Thomsen R, Bjerre D, Ferrero-Miliani L, Busk Madsen M, Jurgens G (2019)
The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid\/methylphenidate ratios
Basic Clin Pharmacol Toxicol 125 :54

Stage C, Dalhoff K, Rasmussen HB, Schow Guski L, Thomsen R, Bjerre D, Ferrero-Miliani L, Busk Madsen M, Jurgens G (2019)
Basic Clin Pharmacol Toxicol 125 :54